KUKJEON PHARMACEUTICAL Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	132,967	136,468	121,998	103,711	85,354
Other Revenue	-0	-0	-	-	-0
Revenue	132,967	136,468	121,998	103,711	85,354
Revenue Growth (YoY)	-1.10%	11.86%	17.63%	21.51%	-
Cost of Revenue	114,875	114,594	96,721	84,195	67,409
Gross Profit	18,092	21,874	25,277	19,515	17,946
Selling, General & Admin	15,095	15,327	12,817	11,451	8,699
Research & Development	4,248	4,684	4,821	3,981	2,651
Amortization of Goodwill & Intangibles	118.43	114.13	89.87	0.34	0.61
Operating Expenses	22,465	21,507	18,768	16,027	11,836
Operating Income	-4,373	366.71	6,509	3,488	6,109
Interest Expense	-6,113	-8,220	-5,735	-1,802	-284.47
Interest & Investment Income	158.29	878.98	1,591	1,037	208.91
Earnings From Equity Investments	-152.32	-57.48	1.15	301.09	-
Currency Exchange Gain (Loss)	-654.27	-1,655	-253.67	-1,215	-869.65
Other Non Operating Income (Expenses)	6,960	10,498	-391.28	9,279	196.4
EBT Excluding Unusual Items	-4,174	1,811	1,722	11,089	5,360
Gain (Loss) on Sale of Investments	1,580	1,831	16.28	67.84	-275.98
Gain (Loss) on Sale of Assets	-49.07	-57.43	-	-69.18	-0
Other Unusual Items	-2,478	-2,706	-	-	-
Pretax Income	-5,121	879.32	1,738	11,088	5,084
Income Tax Expense	-789.56	341.65	-2,954	2,210	1,046
Earnings From Continuing Operations	-4,332	537.67	4,692	8,877	4,038
Minority Interest in Earnings	712.01	1,199	132	70.7	-
Net Income	-3,620	1,736	4,824	8,948	4,038
Net Income to Common	-3,620	1,736	4,824	8,948	4,038
Net Income Growth	-	-64.01%	-46.09%	121.59%	-
Shares Outstanding (Basic)	50	49	49	49	44
Shares Outstanding (Diluted)	50	49	49	51	44
Shares Change (YoY)	2.04%	-	-4.23%	16.16%	-
EPS (Basic)	-72.65	35.38	98.31	182.35	91.54
EPS (Diluted)	-82.99	35.38	98.31	11.35	91.00
EPS Growth	-	-64.01%	766.11%	-87.53%	-
Free Cash Flow	165.07	2,169	-44,269	-29,304	-7,367
Free Cash Flow Per Share	3.31	44.20	-902.17	-571.94	-167.01
Dividend Per Share	10.000	10.000	-	-	-
Gross Margin	13.61%	16.03%	20.72%	18.82%	21.02%
Operating Margin	-3.29%	0.27%	5.33%	3.36%	7.16%
Profit Margin	-2.72%	1.27%	3.95%	8.63%	4.73%
Free Cash Flow Margin	0.12%	1.59%	-36.29%	-28.26%	-8.63%
EBITDA	846.01	5,472	9,643	4,932	7,215
EBITDA Margin	0.64%	4.01%	7.90%	4.75%	8.45%
D&A For EBITDA	5,219	5,105	3,134	1,444	1,106
EBIT	-4,373	366.71	6,509	3,488	6,109
EBIT Margin	-3.29%	0.27%	5.33%	3.36%	7.16%
Effective Tax Rate	-	38.85%	-	19.94%	20.58%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.